Tuesday, May 5, 2015 - Attorneys representing plaintiffs in one of the first Zofran lawsuits filed nationally alleging that prenatal exposure to Zofran caused birth defects offer news on a recent litigation development.* According to court documents filed last week, the defendant, GlaxoSmithKline, has requested the case be dismissed. These Zofran attorneys provide regular Zofran lawsuit news updates to the public, as well as no-cost case review.
"In nearly every products liability lawsuit we handle, there is a motion to dismiss filed by the defendant. Regardless of the end outcome of the case, or what type of settlement is ultimately reached, a first move is often an attempt to have the case dismissed. The court has made no ruling on this motion yet, and our legal team is continuing to pursue the case with zest," comments Jim Onder of the Onder Law Firm, who are representing the plaintiffs.
The case in question is a civil action that was filed in U.S. District Court in Alabama this year by Julie Hunter on behalf of herself and her child, Talon. Talon Hunter was born in 2006 with multiple birth defects including heart defects, physical deformities, and long term health problems which the plaintiff alleges are linked to her ingestion of Zofran during pregnancy, according to court documents. Ms. Hunter took Zofran when it was prescribed by her doctor to treat morning sickness during her pregnancy and alleges she was not warned about the potential for a heightened risk of birth defects, according to court documents. This Zofran lawsuit alleges that GlaxoSmithKline, the maker of Zofran, knew or should have known of the alleged risks of birth defects linked to the drug, according to court documents.
This particular Zofran lawsuit is among the first lodged against GlaxoSmithKline by a mother on behalf of her child, alleging the drug caused the child to develop birth defects. But court documents for this case recount other litigation the company has faced for Zofran and its use to treat morning sickness.** The safety of Zofran for developing fetuses and pregnant mothers was addressed by a high-profile lawsuit filed by the Department of Justice in 2013. GSK paid approximately $3 billion in settlements to resolve charges that include the promotion of Zofran for off-label uses, according to court documents. The safety of Zofran for pregnant mothers has never been confirmed, according to court documents, and federal regulators do not approve of this use of the anti-nausea medication.
Lawyers representing clients in Zofran lawsuits nationwide believe that persons whose child was born with birth defects following Zofran exposure during fetal development may be entitled to compensation for the losses, expenses and damages they have suffered. Persons who meet this description are eligible for a no-cost Zofran lawsuit evaluation with no further obligation. Nationally-renowned for groundbreaking work in drug and product safety litigation against multi-billion dollar corporations, the Onder Law Firm‘s Zofran lawyers have committed their significant resources to providing expert legal representation to women, children and families who believe they may have grounds to file Zofran lawsuits.
The Onder Law Firm welcomes Zofran lawsuit case inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O‘Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling talcum powder lawsuits at www.ZofranBirthDefectsLawsuitCenter.com.
*Julie Hunter and Talon Hunter v GlaxoSmithKline et al, Case No. 2:15-cv-00544-JEO, U.S. District Court, Northern District of Alabama, filed 4/1/15
**United States, et al v. GlaxoSmithKline, Case No. 11-10398-
RWZ, United States District Court in Massachusetts, filed 7/2/12